{"id":"https://genegraph.clinicalgenome.org/r/87a36506-8821-4ddc-8ab8-6fa97936ee02v1.1","type":"EvidenceStrengthAssertion","dc:description":["*DPH5* is located on chromosome 1 at 1p21.2 and encodes the protein diphthamide biosynthesis 5, an essential component in catalyzing the second step of diphthamide moiety formation on eukaryotic elongation factor 2 (*EEF2*).\n\n*DPH5* was first reported in relation to an autosomal recessive developmental disorder, termed DPH5-related diphthamide-deficiency syndrome in 2022 (Shankar et al., 2022 PMID: 35482014). The individuals described in this paper had homozygous or compound heterozygous pathogenic variants in the *DPH5* gene. Their clinical features included craniofacial dysmorphism (broad forehead, frontal bossing, sparse eyebrows, epicanthal folds, broad nasal bridge, triangular chin), short stature, intellectual disability, feeding difficulties, global developmental delay, absence of speech, and delayed ability to walk.\n\nFour variants (missense, frameshift, nonsense) reported in three probands in one publication (PMID: 35482014) are included in this curation. Within this cohort, two families also reported a history of miscarriages and early infant deaths with variable involvement of cardiac and respiratory systems.\n\nThis gene-disease relationship is supported by experimental evidence such as in vitro functional assays (PMID: 3346227), and studies involving cell cultures and non-human model organisms (PMIDs: 28245596, 1508200, 18460012, 35482014). The mechanism of disease is hypothesized to be loss-of-function, whereby pathogenic variants cause a marked decrease in the abundance of the modified histidine residue, known as diphthamide, on *EEF2*. The absence of this modification impairs the function of *EEF2* in maintaining translational fidelity, potentially engendering spurious frameshift events (PMIDs: 23468660, 37246715).\n\nIn summary, there is limited evidence to support the relationship between *DPH5* and autosomal recessive DPH5-related diphthamide-deficiency syndrome. Although more evidence is needed to support a causal role, no convincing evidence has been reported that contradicts this gene-disease relationship. This classification was approved by the ClinGen Intellectual Disability and Autism GCEP on the meeting dated October 24, 2024 (SOP Version 11).\n","*DPH5* is located on chromosome 1 at 1p21.2 and encodes the protein diphthamide biosynthesis 5, an essential component in catalyzing the second step of diphthamide moiety formation on eukaryotic elongation factor 2 (*EEF2*).\n\n*DPH5* was first reported in relation to an autosomal recessive developmental disorder, termed DPH5-related diphthamide-deficiency syndrome in 2022 (Shankar et al., 2022 PMID: 35482014). The individuals described in this paper had homozygous or compound heterozygous pathogenic variants in the *DPH5* gene. Their clinical features included craniofacial dysmorphism (broad forehead, frontal bossing, sparse eyebrows, epicanthal folds, broad nasal bridge, triangular chin), short stature, intellectual disability, feeding difficulties, global developmental delay, absence of speech, and delayed ability to walk.\n\nFour variants (missense, frameshift, nonsense) reported in five probands in one publication (PMID: 35482014) are included in this curation. Within this cohort, two families also reported a history of miscarriages and early infant deaths with variable involvement of cardiac and respiratory systems.\n\nThis gene-disease relationship is supported by experimental evidence such as in vitro functional assays (PMID: 3346227), and studies involving cell cultures and non-human model organisms (PMIDs: 28245596, 1508200, 18460012, 35482014). The mechanism of disease is hypothesized to be loss-of-function, whereby pathogenic variants cause a marked decrease in the abundance of the modified histidine residue, known as diphthamide, on *EEF2*. The absence of this modification impairs the function of *EEF2* in maintaining translational fidelity, potentially engendering spurious frameshift events (PMIDs: 23468660, 37246715).\n\nIn summary, there is limited evidence to support the relationship between *DPH5* and autosomal recessive DPH5-related diphthamide-deficiency syndrome. Although more evidence is needed to support a causal role, no convincing evidence has been reported that contradicts this gene-disease relationship. This classification was approved by the ClinGen Intellectual Disability and Autism GCEP on the meeting dated October 24, 2024 (SOP Version 11).\n"],"dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/87a36506-8821-4ddc-8ab8-6fa97936ee02","GCISnapshot":"https://genegraph.clinicalgenome.org/r/7b1259e3-d4e7-47c8-a617-cef3cc2dd3d0","calculatedEvidenceStrength":"Limited","changes":{"id":"cg:summaryChange"},"contributions":[{"id":"https://genegraph.clinicalgenome.org/r/7b1259e3-d4e7-47c8-a617-cef3cc2dd3d0_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10006","date":["2024-10-24T16:00:00.000Z","2024-10-23T22:00:00.000Z"],"role":"Approver"},{"id":"https://genegraph.clinicalgenome.org/r/7b1259e3-d4e7-47c8-a617-cef3cc2dd3d0_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10006","date":"2025-05-28T09:58:58.020Z","role":"Publisher"}],"curationReasons":["ErrorClarification"],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7b1259e3-d4e7-47c8-a617-cef3cc2dd3d0_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1cc491e7-c8cb-40ea-9007-66387d06abc7_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1cc491e7-c8cb-40ea-9007-66387d06abc7","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/35482014","rdfs:label":"Proband 2A","ageType":"AgeAtReport","ageUnit":"Years","ageValue":9,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/85da4395-3d18-4417-8a7a-0160be7b41ba","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_015958.3(DPH5):c.329A>G (p.Asn110Ser)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA972520"}},{"id":"https://genegraph.clinicalgenome.org/r/193b7774-336e-4d02-9f15-aeae10f4d52f","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_015958.3(DPH5):c.619C>T (p.Arg207Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA972432"}}],"phenotypes":["obo:HP_0001263","obo:HP_0031936","obo:HP_0000348","obo:HP_0001182","obo:HP_0004322","obo:HP_0001250","obo:HP_0009890","obo:HP_0025534","obo:HP_0001838","obo:HP_0009085","obo:HP_0001561","obo:HP_0011398","obo:HP_0002353","obo:HP_0000653","obo:HP_0001558","obo:HP_0001252","obo:HP_0045075","obo:HP_0001344"],"sex":"Male","variant":[{"id":"https://genegraph.clinicalgenome.org/r/a710445b-c0b8-48e0-8229-d26f5f1f29d2_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/35482014","allele":{"id":"https://genegraph.clinicalgenome.org/r/193b7774-336e-4d02-9f15-aeae10f4d52f"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:TwoVariantsInTrans"}},{"id":"https://genegraph.clinicalgenome.org/r/5912a04a-f77e-4187-a89a-ee2c8281983b_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/35482014","allele":{"id":"https://genegraph.clinicalgenome.org/r/85da4395-3d18-4417-8a7a-0160be7b41ba"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:TwoVariantsInTrans"}}]},{"id":"https://genegraph.clinicalgenome.org/r/5912a04a-f77e-4187-a89a-ee2c8281983b","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5912a04a-f77e-4187-a89a-ee2c8281983b_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/5912a04a-f77e-4187-a89a-ee2c8281983b_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Unclear effects on DPH5 enzymatic activity based on ADP-ribosylation experiments in MCF7 cells and for the orthologous variant equivalent in BY4741 yeast strains. Clear growth defect in yeast harboring the equivalent yeast variant based on sensitivity to the diphthamide-indicative translation inhibitor drug hygromycin B.","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/a710445b-c0b8-48e0-8229-d26f5f1f29d2","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a710445b-c0b8-48e0-8229-d26f5f1f29d2_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/a710445b-c0b8-48e0-8229-d26f5f1f29d2_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Complete loss of DPH5 enzymatic activity based on ADP-ribosylation experiments in MCF7 cells.","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2.5},{"id":"https://genegraph.clinicalgenome.org/r/cea932bc-b6fd-4948-baf6-07f469cfde84_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/cea932bc-b6fd-4948-baf6-07f469cfde84","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/35482014","rdfs:label":"Proband 1A","ageType":"AgeAtReport","ageUnit":"Years","ageValue":10,"allele":{"id":"https://genegraph.clinicalgenome.org/r/904f4b96-e1ab-4743-9b51-8a464cacddac","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_015958.3(DPH5):c.779A>G (p.His260Arg)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA972358"}},"phenotypes":["obo:HP_0002015","obo:HP_0002007","obo:HP_0005643"],"sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/52260e7c-41d6-48df-b634-2fd86beeab9e_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/35482014","allele":{"id":"https://genegraph.clinicalgenome.org/r/904f4b96-e1ab-4743-9b51-8a464cacddac"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:Homozygous"}}},{"id":"https://genegraph.clinicalgenome.org/r/52260e7c-41d6-48df-b634-2fd86beeab9e","type":"EvidenceLine","calculatedScore":1.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/52260e7c-41d6-48df-b634-2fd86beeab9e_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/52260e7c-41d6-48df-b634-2fd86beeab9e_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Unclear effects on DPH5 enzymatic activity based on ADP-ribosylation experiments in MCF7 cells and for the orthologous variant equivalent in BY4741 yeast strains. Clear growth defect in yeast harboring the equivalent yeast variant based on sensitivity to the diphthamide-indicative translation inhibitor drug hygromycin B.","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1.0}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/d790b1ef-4e61-4ec3-9623-770fa9770ad8_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d790b1ef-4e61-4ec3-9623-770fa9770ad8","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/35482014","rdfs:label":"Proband 3A","ageType":"AgeAtDeath","ageUnit":"Days","ageValue":11,"allele":{"id":"https://genegraph.clinicalgenome.org/r/3b3d79a5-63fc-434d-a154-eca0e9f07d78","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_015958.3(DPH5):c.521dup (p.Asn174LysfsTer10)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2586967051"}},"firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0001631","obo:HP_0002714","obo:HP_0002280","obo:HP_0045075","obo:HP_0000431","obo:HP_0001561","obo:HP_0000248","obo:HP_0000286","obo:HP_0000637","obo:HP_0000337","obo:HP_0001642","obo:HP_4000142","obo:HP_0001698","obo:HP_0011398","obo:HP_0001629"],"sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/d0eb0d94-edf0-45cc-b101-6b5ef221b7d1_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/35482014","allele":{"id":"https://genegraph.clinicalgenome.org/r/3b3d79a5-63fc-434d-a154-eca0e9f07d78"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}},{"id":"https://genegraph.clinicalgenome.org/r/d0eb0d94-edf0-45cc-b101-6b5ef221b7d1","type":"EvidenceLine","dc:description":"The ClinGen Intellectual Disability and Autism Gene Curation Expert Panel consensus is not to score any individual proband above 2 points. Furthermore, given the consanguinity present within the family, an elevated level of homozygous variants is not unexpected.","calculatedScore":4,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d0eb0d94-edf0-45cc-b101-6b5ef221b7d1_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/d0eb0d94-edf0-45cc-b101-6b5ef221b7d1_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Minimal DPH5 enzymatic activity signal detectable based on ADP-ribosylation experiments in MCF7 cells.","functionalDataSupport":"Yes"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/7b1259e3-d4e7-47c8-a617-cef3cc2dd3d0_seg_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/67ec6d5b-1504-4a0a-8e5c-da1188ab39a4_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/35482014","rdfs:label":"Family 1","family":{"id":"https://genegraph.clinicalgenome.org/r/67ec6d5b-1504-4a0a-8e5c-da1188ab39a4","type":"Family","rdfs:label":"Family 1","member":{"id":"https://genegraph.clinicalgenome.org/r/cea932bc-b6fd-4948-baf6-07f469cfde84"}},"phenotypePositiveAllelePositive":2,"phenotypes":["obo:HP_0031936","obo:HP_0001344","obo:HP_0002353","obo:HP_0001182","obo:HP_0002714","obo:HP_0045075","obo:HP_0000337","obo:HP_0004322","obo:HP_0000341","obo:HP_0001263","obo:HP_0011968","obo:HP_0000020","obo:HP_0000286","obo:HP_0000431","obo:HP_0100021"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/cea932bc-b6fd-4948-baf6-07f469cfde84"}},{"id":"https://genegraph.clinicalgenome.org/r/dfc15841-fc69-40a7-9390-5e3fb2cf37a5_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/35482014","rdfs:label":"Family 2","family":{"id":"https://genegraph.clinicalgenome.org/r/dfc15841-fc69-40a7-9390-5e3fb2cf37a5","type":"Family","rdfs:label":"Family 2","member":{"id":"https://genegraph.clinicalgenome.org/r/1cc491e7-c8cb-40ea-9007-66387d06abc7"}},"phenotypePositiveAllelePositive":2,"phenotypes":["obo:HP_0031936","obo:HP_0001250","obo:HP_0004322","obo:HP_0001344","obo:HP_0001263","obo:HP_0001561","obo:HP_0001182","obo:HP_0045075","obo:HP_0002353","obo:HP_0011398"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/1cc491e7-c8cb-40ea-9007-66387d06abc7"}},{"id":"https://genegraph.clinicalgenome.org/r/85d431d2-73ee-4d5b-9f8c-6dc0cd1088fb_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/35482014","rdfs:label":"Family 3","family":{"id":"https://genegraph.clinicalgenome.org/r/85d431d2-73ee-4d5b-9f8c-6dc0cd1088fb","type":"Family","rdfs:label":"Family 3","member":{"id":"https://genegraph.clinicalgenome.org/r/d790b1ef-4e61-4ec3-9623-770fa9770ad8"}},"phenotypePositiveAllelePositive":1,"proband":{"id":"https://genegraph.clinicalgenome.org/r/d790b1ef-4e61-4ec3-9623-770fa9770ad8"}}],"specifiedBy":"GeneValiditySegregationEvidenceCriteria","strengthScore":0}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":5.5},{"id":"https://genegraph.clinicalgenome.org/r/7b1259e3-d4e7-47c8-a617-cef3cc2dd3d0_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7b1259e3-d4e7-47c8-a617-cef3cc2dd3d0_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2b9625d4-862c-48ba-abab-5b8d184050d5","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/90bf9645-a27c-4c08-8595-5fbae6ccd033","type":"Finding","dc:description":"DPH5 is a member of the dipthamide synthesis pathway, responsible for methylating both the amino and carboxyl groups of the 3-Amino-3-carboxypropyl-modified eEF2 intermediate. This modification is crucial for the maintenance of translation fidelity through suppression of ribosomal frameshifting.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23468660","rdfs:label":"DPH5-EEF2 Co-Immunoprecipitation","demonstrates":{"id":"obo:MI_0915"}}],"specifiedBy":"GeneValidityProteinInteractionCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":0.5}],"evidenceStrength":"Limited","sequence":10491,"specifiedBy":"GeneValidityCriteria11","strengthScore":6,"subject":{"id":"https://genegraph.clinicalgenome.org/r/fQDGTvi4U88","type":"GeneValidityProposition","disease":"obo:MONDO_0100503","gene":"hgnc:24270","modeOfInheritance":"obo:HP_0000007"},"version":"1.1","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_7b1259e3-d4e7-47c8-a617-cef3cc2dd3d0-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}